A. Tan

Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.

L. Rybicki, M. Strome, R. Esclamado, 2007, Archives of otolaryngology--head & neck surgery.

Geographic differences in approach to advanced gastric cancer: Is there a standard approach?

B. El-Rayes, Minsig Choi, A. Tan, 2013, Critical reviews in oncology/hematology.

Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation

F. Aucejo, P. Elson, R. Kim, 2010, Oncology.

International Journal of Organ Transplantation Medicine Serum Vascular Endothelial Growth Factor Level in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Experience of a Single Western Center

F. Aucejo, R. Kim, A. Tan, 2022 .

Prognostic roles of human equilibrative transporter 1 (hENT‐1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer

Kevin Lai, L. Rybicki, John Jiang, 2011, Cancer.

Is There a Role for Adjuvant Treatment after Hepatic Resection for Hepatocellular Carcinoma?

F. Aucejo, R. Kim, A. Tan, 2010, Oncology.

Controversies in the management of early-stage germ cell tumors

T. Gilligan, A. Tan, 2009, Current oncology reports.

Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation

Wei Zhang, J. Fung, F. Aucejo, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

What is the indication for sorafenib in hepatocellular carcinoma? A clinical challenge.

F. Aucejo, M. Byrne, A. Tan, 2011, Oncology.

A Single Institution Review of Adjuvant Therapy Outcomes for Resectable Pancreatic Adenocarcinoma: Outcome and Prognostic Indicators

P. Elson, R. Kim, K. Almhanna, 2010, Journal of Gastrointestinal Surgery.